Intra Cellular Therapies | ITCI - Кредиторская задолженность



Кредиторская задолженность Изменить Дата
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
ALKERMES USD 102.36M 5.59M 2026-03
BioCryst Pharmaceuticals USD 10.96M 4.87M 2026-03
Biogen USD 358.5M 73.5M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Cytokinetics USD 24.71M 80.91M 2026-03
Esperion Therapeutics USD 68.41M 3.34M 2026-03
Gilead Sciences USD 645M 70M 2026-03
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
J&J USD 10.46B 1.53B 2026-03
Minerva Neurosciences USD 640K 305K 2025-12
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.46B 99M 2025-12
Prothena USD 4.3M 1.58M 2026-03
RedHill Biopharma USD 731K 104K 2025-12
Supernus Pharmaceuticals USD 10.17M 97.63M 2026-03
United Therapeutics USD 498.3M 491.2M 2026-03
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12